These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32350715)

  • 21. ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
    Millen EC; Cavalcante FP
    Ann Surg Oncol; 2022 Feb; 29(2):1096-1097. PubMed ID: 34561776
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer.
    Houpu Y; Fei X; Yang Y; Fuzhong T; Peng L; Bo Z; Lin C; Yingming C; Miao L; Hongjun L; Siyuan W; Yuan P; Danhua S; Shu W
    J Surg Oncol; 2019 Sep; 120(4):587-592. PubMed ID: 31309573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of the clinically node-negative axilla: what have we learned from the clinical trials?
    Pilewskie ML; Morrow M
    Oncology (Williston Park); 2014 May; 28(5):371-8. PubMed ID: 25004648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASO Author Reflections: A Negative Axillary Clinical Exam Adequately Identifies Clinically Node-Positive Patients who Downstage After NAC and are Candidates for SLNB.
    Moo TA; Morrow M
    Ann Surg Oncol; 2019 Dec; 26(13):4244-4245. PubMed ID: 31617121
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status.
    Milner TD; de Lusignan S; Jones S; Jackson PA; Layer GT; Kissin MW; Irvine TE
    Breast; 2015 Oct; 24(5):568-75. PubMed ID: 26032111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.
    Chen JJ; Wu J
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):293-301. PubMed ID: 20663684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer.
    Lv M; Luo S
    Ann Surg Oncol; 2021 Sep; 28(9):5110-5111. PubMed ID: 33528707
    [No Abstract]   [Full Text] [Related]  

  • 33. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Postoperative Complications After 303 Sentinel Lymph Node Identification Procedures Using the SentiMag® Method in Breast Cancer Patients.
    Lorek A; Stojčev Z; Zarębski W; Kowalczyk M; Szyluk K
    Med Sci Monit; 2019 Apr; 25():3154-3160. PubMed ID: 31032820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
    Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
    Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.
    Nadeem RM; Gudur LD; Saidan ZA
    Clin Breast Cancer; 2014 Aug; 14(4):272-9. PubMed ID: 25037530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality-of-life impact of sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients.
    Belmonte R; Garin O; Segura M; Pont A; Escalada F; Ferrer M
    Value Health; 2012; 15(6):907-15. PubMed ID: 22999141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer.
    Ponzone R; Ruatta F; Gatti M; Castellano I; Geuna E; Amato G; Kubatzki F; Sgandurra P; Sapino A; Montemurro F
    Cancer Treat Rev; 2016 Jul; 48():1-7. PubMed ID: 27262016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?
    Kantor O; Pesce C; Liederbach E; Wang CH; Winchester DJ; Yao K
    Breast J; 2017 Sep; 23(5):554-562. PubMed ID: 28295828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.